Scientific and technological advances are making it easier than ever for life sciences companies to expand clinical trial candidate bases, so, in many cases, they should be able to more accurately reflect their real-world patient population. Learn 5 key considerations for assessing and restructuring clinical trial design and processes to achieve better representation of target populations.
Use technology to expand recruitment
Decide who is included and excluded - and why
Align the diversity of the population with the clinical trial phase
Consider the regulatory landscape and target markets
Reevaluate your company's level of responsibility
Read the full byline by Guidehouse experts Vijaya Prajwala, Liisa M. Eisenlohr, and Enno Behrendt.